Kalpime TZ 1000mg/125mg Injection
Marketer
Kalmia Healthcare
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Kalpime TZ 1000mg/125mg Injection
Tazocin 1000mg/125mg Injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be solely under medical guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Typical side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain) which usually subside. Severe or persistent side effects require immediate medical attention. Allergic reactions (skin rash, itching, edema, respiratory distress) necessitate prompt medical consultation. Prior to commencement, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness.
Uses of Kalpime TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Kalpime TZ 1000mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; please refrain from self-medicating.
Common Side effects of Kalpime TZ 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Kalpime TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kalpime TZ 1000mg/125mg Injection works:
Kalpime TZ Injection, containing 1000mg Cefepime and 125mg Tazobactam, combines an antibiotic with a beta-lactamase inhibitor. Cefepime's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise deactivate Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Kalpime TZ 1000mg/125mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Kalpime TZ 1000mg/125mg Injection is typically regarded as safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Kalpime TZ (1000mg/125mg) is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Kalpime TZ 1000mg/125mg Injection, temporary blurred vision may occur. Refrain from driving until your vision has returned to normal.
KidneyCAUTION
Patients with impaired kidney function should use Kalpime TZ 1000mg/125mg Injection cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Kalpime TZ 1000mg/125mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Kalpime TZ 1000mg/125mg Injection :
Should you forget a scheduled dose of Kalpime TZ 1000mg/125mg Injection, seek advice from your physician.
Facts to Know About Kalpime TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently